Sign in
4

Changes in Ownership

X4 Pharmaceuticals, Inc Filed Acc 0001501697-25-000035

Executive Chairman bought 86,206 shares at $2.90 ($249,997)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Craig Adam R Executive Chairman 2025-10-23 Purchase +86,206 $2.90 $249,997 376,087 D
Open-market purchases · 86,206 sh · avg $2.90 · $249,997
Loading xslF345X05/wk-form4_1761604837.xml…